Watch 7:26
Fighting malaria in the remote reaches of Cambodia
Malaria causes nearly half a million deaths worldwide every year. Ninety percent of them are in sub-Saharan Africa, where poor infrastructure limits delivery of drugs. But now there is worry that those drugs are losing effectiveness as disease strains become…
Trimming these invasive flowers could help curb malaria
Biologists working in Mali found an invasive tree also doubles as a buffet and a haven for malaria-carrying mosquitoes.
Are you a mosquito magnet? Own socks? This study is for you
Researchers are studying the way twins smell for clues about the genetic basis of mosquito appeal.
Researchers use new ‘gene drive’ to create malaria-resistant mosquitoes
California researchers hatched some malaria-resistant mosquitoes and then gave evolution a shove — using a groundbreaking technology to ensure the insects pass on that protective gene as they reproduce, with implications far beyond the promise of fighting malaria.
Scientists find experimental evidence for the first time that a vaccine can make a virus worse.
High-tech maps may help researchers understand and predict disease outbreaks like malaria, an illness that kills between 600,000 and 1 million people each year. Scientists have begun using temperatures, rainfall patterns and other data to better target areas most at…
In other news Friday, cities across Egypt erupted in fresh violence as protesters accused the ruling military of failing to stop a soccer riot that killed 74 people this week. Also, malaria may be killing twice as many people as…
Each year, pneumonia kills more children around the world than malaria, measles and HIV combined. Ray Suarez reports from Nicaragua on efforts to combat the lung infection, which is the leading killer of children under the age of five.
An experimental vaccine against malaria, an oftentimes-deadly disease that half the world is exposed to, is still in trials, but it could be in production by 2015. Jeffrey Brown discusses the potential impact of the vaccine with GlaxoSmithKline CEO Andrew…
